SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-150357
Filing Date
2024-05-30
Accepted
2024-05-30 16:25:30
Documents
13
Period of Report
2024-05-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d798417d8k.htm   iXBRL 8-K 21657
  Complete submission text file 0001193125-24-150357.txt   139712

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20240529.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20240529_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20240529_pre.xml EX-101.PRE 10830
17 EXTRACTED XBRL INSTANCE DOCUMENT d798417d8k_htm.xml XML 3545
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 241005689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)